Health
China’s Clover says its COVID-19 vaccine candidate shows immune response in mice – Reuters
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against…
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against the original strain of the virus and some variants during animal testing.
Clover said in a statement its vaccine candidate demonstrated a “neutralisation” against the South African, Brazilian and UK variants among mice.
The company is testing a COVID-19 vaccine candidate containing an adjuvant, typically designed to boost the efficacy…
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business19 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
General6 hours agoThe right-wing stupidity repeating Liberal Party history
-
General6 hours agoDefence minister won’t say if security agencies or Trump administration pushed for Darwin Port backflip